Ovarian Malignancy Risk-ROMA
Order Name
Ovarian Risk
Test Number: 5195163
Revision Date 09/09/2024
Test Number: 5195163
Revision Date 09/09/2024
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Ovarian Malignancy Risk-ROMA
|
Electrochemiluminescence Immunoassay (ECLIA) | N/A |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 1.75 mL (1 mL) | Serum | Clot Activator (SST or Red No-Gel) | Refrigerated |
| Instructions | Specimen: Serum Storage requirements: Refrigerate; stable for 5 days at room temperature or 14 days refrigerated. ?Causes for Rejection: Gross hemolysis |
|||
| GENERAL INFORMATION | |
|---|---|
| Expected TAT | 1-3 days |
| Clinical Use | The ROMA™ (Risk of Ovarian Malignancy Algorithm) calculation combines the results of the Roche Elecsys HE4 assay, Elecsys CA 125 II assay and menopausal status into a numerical score (Roche). The ROMA value is intended to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery. ROMA Calculation is indicated for women who meet the following criteria: over age 18; ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist. ROMA values must be interpreted in conjunction with an independent clinical and radiological assessment. The test is not intended as a screening or stand-alone diagnostic assay. |
| CPT Code(s) | 81500 |
| Service Provided By |  |
| Lab Section | Reference Lab |